Blood vessel (cut, vasospasm)

[{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab82bb799d19b0/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab82bb799d19b0/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab8234349d19af/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab8234349d19af/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab8289009d19ae/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab8289009d19ae/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab8244cc9d19ad/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab8244cc9d19ad/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab824a3a9d19ac/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab824a3a9d19ac/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab82e7379d19ab/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab82e7379d19ab/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab82d8c59d19aa/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab82d8c59d19aa/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab82f18b9d19a9/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab82f18b9d19a9/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab8273e19d19a8/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab8273e19d19a8/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab823d179d19a7/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab823d179d19a7/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab824e0f9d19a6/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab824e0f9d19a6/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab821b489d19a5/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab821b489d19a5/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab822d179d19a4/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab822d179d19a4/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab82fde49d19a3/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab82fde49d19a3/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab820a359d19a2/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab820a359d19a2/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab822cb69d19a1/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab822cb69d19a1/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab82cd0e9d19a0/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab82cd0e9d19a0/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab821a569d199f/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab821a569d199f/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab82751d9d199e/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab82751d9d199e/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab82bace9d199d/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab82bace9d199d/65a561e53eab82b2eb9d199b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a562113eab827cfe9d199c/65a561e53eab82b2eb9d199b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a562113eab827cfe9d199c/65a561e53eab82b2eb9d199b.png"}]